Are allogeneic blood transfusions associated with decreased survival after surgical treatment for spinal metastases?

Spine Journal

Volumn 16, Issue 8, 2016, Pages 951-961

  Paulino Pereira, Nuno Rui ^a   Beks, Reinier B ^a   Janssen, Stein J ^a   Harris, Mitchel B ^b   Hornicek, Francis J ^a   Ferrone, Marco L ^b   Schwab, Joseph H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Allogeneic blood transfusion; Bone metastases; Mortality; Spinal metastases; Spine; Survival

Indexed keywords

CALCIUM; HEMOGLOBIN;

ADULT; AGED; ALLOGENEIC BLOOD TRANSFUSION; ARTICLE; BLOOD TRANSFUSION; BRAIN METASTASIS; CALCIUM BLOOD LEVEL; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL LABORATORY; COHORT ANALYSIS; DOSE RESPONSE; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; LIVER METASTASIS; LUNG METASTASIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE MYELOMA; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SPINAL CORD DECOMPRESSION; SPINAL CORD METASTASIS; SPINE STABILIZATION; SPINE SURGERY; SYSTEMIC THERAPY; TASK PERFORMANCE; UNIVERSITY HOSPITAL; VERTEBRECTOMY; ADVERSE EFFECTS; BONE NEOPLASMS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RADIOSURGERY; SECONDARY; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS;

AGED; BLOOD TRANSFUSION; BONE NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RADIOSURGERY; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84963644278     PISSN: 15299430     EISSN: 18781632     Source Type: Journal    
DOI: 10.1016/j.spinee.2016.03.043     Document Type: Article

References (40)

1. [1] Berenholtz, S.M., Pronovost, P.J., Mullany, D., Garrett, E., Ness, P.M., Dorman, T., et al. Predictors of transfusion for spinal surgery in Maryland, 1997 to 2000. Transfusion 42 (2002), 183–189.
2. [2] Nuttall, G.A., Horlocker, T.T., Santrach, P.J., Oliver, W.C. Jr, Dekutoski, M.B., Bryant, S., Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine 25 (2000), 596–601.
3. [3] Butler, J.S., Burke, J.P., Dolan, R.T., Fitzpatrick, P., O'Byrne, J.M., McCormack, D., et al. Risk analysis of blood transfusion requirements in emergency and elective spinal surgery. Eur Spine J 20 (2011), 753–758.
4. [4] Janssen, S.J., Braun, Y., Wood, K.B., Cha, T.D., Schwab, J.H., Allogeneic blood transfusions and postoperative infections after lumbar spine surgery. Spine J 15 (2015), 901–909.
5. [5] Acheson, A.G., Brookes, M.J., Spahn, D.R., Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg 256 (2012), 235–244.
6. [6] Amato, A., Pescatori, M., Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev(1), 2006 CD005033.
7. [7] Uccella, S., Ghezzi, F., Cromi, A., Bogani, G., Formenti, G., Donadello, N., et al. Perioperative allogenic blood transfusions and the risk of endometrial cancer recurrence. Arch Gynecol Obstet 287 (2013), 1009–1016.
8. [8] Katoh, H., Yamashita, K., Kokuba, Y., Satoh, T., Ozawa, H., Hatate, K., et al. Surgical resection of stage IV colorectal cancer and prognosis. World J Surg 32 (2008), 1130–1137.
9. [9] Margulis, V., Shariat, S.F., Rapoport, Y., Rink, M., Sjoberg, D.D., Tannir, N.M., et al. Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. Eur Urol 63 (2013), 947–952.
10. [10] Schiergens, T.S., Rentsch, M., Kasparek, M.S., Frenes, K., Jauch, K.W., Thasler, W.E., Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. Dis Colon Rectum 58 (2015), 74–82.
11. [11] Zakaria, S., Donohue, J.H., Que, F.G., Farnell, M.B., Schleck, C.D., Ilstrup, D.M., et al. Hepatic resection for colorectal metastases: value for risk scoring systems?. Ann Surg 246 (2007), 183–191.
12. [12] Cata, J.P., Wang, H., Gottumukkala, V., Reuben, J., Sessler, D.I., Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth 110 (2013), 690–701.
13. [13] Janssen, S.J., Braun, Y., Ready, J.E., Raskin, K.A., Ferrone, M.L., Hornicek, F.J., et al. Are allogeneic blood transfusions associated with decreased survival after surgery for long-bone metastatic fractures?. Clin Orthop Relat Res 473 (2015), 2343–2351.
14. [14] Clausen, C., Lonn, L., Morgen, S.S., Nielsen, M.B., Frevert, S.C., Johansson, P.I., et al. Perioperative blood transfusion does not decrease survival after surgical treatment of spinal metastases. Eur Spine J 23 (2014), 1791–1796.
15. [15] Nathan, S.S., Healey, J.H., Mellano, D., Hoang, B., Lewis, I., Morris, C.D., et al. Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol 23 (2005), 6072–6082.
16. [16] Bryant, D.H.T., Roberts, R., Guyatt, G., How many patients? How many limbs? Analysis of patients or limbs in the orthopaedic literature: a systematic review. J Bone Joint Surg Am 88 (2006), 41–45.
17. [17] Huntington, J.T., Butterfield, M., Fisher, J., Torrent, D., Bloomston, M., The Social Security Death Index (SSDI) most accurately reflects true survival for older oncology patients. Am J Cancer Res 3 (2013), 518–522.
18. [18] Poeran, J., Rasul, R., Suzuki, S., Danninger, T., Mazumdar, M., Opperer, M., et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ, 349, 2014, g4829.
19. [19] Quan, H., Li, B., Couris, C.M., Fushimi, K., Graham, P., Hider, P., et al. Updating and validating the Charlson Comorbidity Index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173 (2011), 676–682.
20. [20] Tokuhashi, Y., Matsuzaki, H., Oda, H., Oshima, M., Ryu, J., A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 30 (2005), 2186–2191.
21. [21] Tomita, K., Kawahara, N., Kobayashi, T., Yoshida, A., Murakami, H., Akamaru, T., Surgical strategy for spinal metastases. Spine 26 (2001), 298–306.
22. [22] Kirshblum, S.C., Burns, S.P., Biering-Sorensen, F., Donovan, W., Graves, D.E., Jha, A., et al. International standards for neurological classification of spinal cord injury (revised 2011). J Spinal Cord Med 34 (2011), 535–546.
23. [23] Allison, P., Survival analysis using SAS®: a practical guide. 2010, SAS® Institute, Cary, NC.
24. [24] Katz, M.H., Hauck, W.W., Proportional hazards (Cox) regression. J Gen Intern Med 8 (1993), 702–711.
25. [25] Adair, R.A., Young, A.L., Cockbain, A.J., Malde, D., Prasad, K.R., Lodge, J.P., et al. Repeat hepatic resection for colorectal liver metastases. Br J Surg 99 (2012), 1278–1283.
26. [26] Haruki, K., Shiba, H., Fujiwara, Y., Furukawa, K., Wakiyama, S., Ogawa, M., et al. Perioperative change in peripheral blood monocyte count may predict prognosis in patients with colorectal liver metastasis after hepatic resection. J Surg Oncol 106 (2012), 31–35.
27. [27] van der Linden, Y.M., Dijkstra, S.P., Vonk, E.J., Marijnen, C.A., Leer, J.W., Dutch Bone Metastasis Study G. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 103 (2005), 320–328.
28. [28] Bauer, H.C., Wedin, R., Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand 66 (1995), 143–146.
29. [29] Sioutos, P.J., Arbit, E., Meshulam, C.F., Galicich, J.H., Spinal metastases from solid tumors. Analysis of factors affecting survival. Cancer 76 (1995), 1453–1459.
30. [30] Chi, J.H., Gokaslan, Z., McCormick, P., Tibbs, P.A., Kryscio, R.J., Patchell, R.A., Selecting treatment for patients with malignant epidural spinal cord compression-does age matter?: results from a randomized clinical trial. Spine 34 (2009), 431–435.
31. [31] Walls, J., Bundred, N., Howell, A., Hypercalcemia and bone resorption in malignancy. Clin Orthop Relat Res 312 (1995), 51–63.
32. [32] Piccirillo, J.F., Tierney, R.M., Costas, I., Grove, L., Spitznagel, E.L. Jr, Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291 (2004), 2441–2447.
33. [33] Forsberg, J.A., Eberhardt, J., Boland, P.J., Wedin, R., Healey, J.H., Estimating survival in patients with operable skeletal metastases: an application of a Bayesian belief network. PLoS ONE, 6, 2011, e19956.
34. [34] Xie, X., Yao, M., Chen, X., Lu, W., Lv, Q., Wang, K., et al. Reduced red blood cell count predicts poor survival after surgery in patients with primary liver cancer. Medicine, 94, 2015, e577.
35. [35] Mantovani, A., Allavena, P., Sica, A., Balkwill, F., Cancer-related inflammation. Nature 454 (2008), 436–444.
36. [36] Jansson, K.A., Bauer, H.C., Survival, complications and outcome in 282 patients operated for neurological deficit due to thoracic or lumbar spinal metastases. Eur Spine J 15 (2006), 196–202.
37. [37] American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies, Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 105 (2006), 198–208.
38. [38] Nota, S.P., Braun, Y., Ring, D., Schwab, J.H., Incidence of surgical site infection after spine surgery: what is the impact of the definition of infection?. Clin Orthop Relat Res 473 (2015), 1612–1619.
39. [39] Qiao, Z., Jia, N., He, Q., Does preoperative transarterial embolization decrease blood loss during spine tumor surgery?. Interv Neuroradiol 21 (2015), 129–135.
40. [40] Thiex, R., Harris, M.B., Sides, C., Bono, C.M., Frerichs, K.U., The role of preoperative transarterial embolization in spinal tumors. A large single-center experience. Spine J 13 (2013), 141–149.